How Big Pharma Infiltrated the Boston Museum of Science
HEALTH, 29 Jan 2018
23 Jan 2018 – Do you overeat? Did your boyfriend just break up with you? Does no one return your emails? Do you fall asleep at night and wake up in the morning? If so, you may be suffering from mental illness! Mental illness is a highly stigmatized, life-long condition, that millions do not even realize they have and only a pharmaceutical drug can fix says Pharma and its operatives.
Few marketing gambits have been as successful as Pharma’s elevation of everyday symptoms into “mental illness.” It has enabled it to aggregate “patient” groups to petition lawmakers, insurers and Medicaid and Medicare for payment of high-priced psychiatric drugs. It has allowed groups like the Pharma-funded Active Minds and NAMI to infiltrate college campuses and proclaim the ups and downs of growing up and college life “mental illness”––growing the market. And now it has allowed it to infiltrate Boston’s Museum of Science.
Last spring an exhibit called Many Faces of Our Mental Health debuted at the museum, taking Pharma’s everyone-is-mentally-ill message to museum goers and the general public. Visitors to the exhibit “might gain new insights and better understand the complex nature of mental health,” said the press release. They might “reflect on how mental health affects their own lives or the lives of friends and family.” Hey, they might have “mental illness” too!
Funders of the exhibit included the Pharma-backed NAMI and the Sidney R. Baer, Jr. and Sidney A. Swensrud foundations both of which stress screening and early intervention for childhood “mental illness.” Both mechanisms are widely seen as a way to grow the market for psychiatric drugs. In fact, the Baer Foundation funds the Pharma-funded Joan Luby who not only finds mental abnormalities in toddlers, she thinks they are present in “late preterm” babies!
There is no biological test for “mental illness”––whether depression, anxiety or bipolar disorder––and until recently, depression and anxiety were not even considered “mental illness.” Now, television drug ads, faux patient groups and faux public service announcements and online quizzes have produced a groundswell of self-diagnosed “mentally ill” people. Pharma funded patient groups like Active Minds and NAMI have even made the badge of mental illness “cool” on high school and college campuses.
“When insurers balk at reimbursing patients for new prescription medications,” says the Los Angeles Times, these groups “typically swing into action, rallying sufferers to appear before public and consumer panels [and] contact lawmakers.”
With an estimated one quarter of the population now taking expensive psychiatric drugs, Pharma’s everyone-is-mentally-ill ploy enriches Wall Street and raises our health care costs. Gone are the days when bad moods were attributed to problems with finance, romance, debt, jobs, housing, careers, family, marriages and health. Worse, Pharma’s everyone-is-mentally-ill ruse siphons off legitimate, activist anger at a government system that keeps people poor and powerless by suggesting they have a personal problem and the answer is a happy pill. Also known as—retreat into individualism.
“People living with mental illness can lead very productive lives and this exhibition highlights this important concept,” said Christine Reich, vice president of exhibit development and conservation, about the Museum of Science exhibit adding this commercial for expensive Pharma drugs: “Mental illness is greatly affect[ed] by the treatment options that are available.”
Martha Rosenberg is a freelance journalist and the author of the highly acclaimed Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, published by Prometheus Books.
DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.